The Reverse Trial led by Chief Principal Investigator, Professor Eun-Seok Shin is an international research initiative aimed to revolutionise the treatment of large coronary artery disease. CVSKL’s renowned interventional cardiologists, Datuk Dr. Rosli Mohd Ali, Dr. Al Fazir Omar, Dr. Choo Gim Hooi, and Dr. Jayakhanthan Kolanthaivelu, will be actively contributing their expertise to this ongoing research.
Our collaboration with B. Braun B. Braun Group, a global leader in healthcare innovation, underscores our commitment to pushing the boundaries of progressive cardiovascular solutions for patients worldwide. The REVERSE Trial represents a significant leap forward in advancing percutaneous coronary interventions through pioneering products like the SeQuent® Please NEO drug-coated balloon.
Join us on this incredible journey as we set new standards in cardiovascular healthcare worldwide! For more information about the trial, click here: https://clinicaltrials.gov/study/NCT05846893
Previous
Next
